Mirae Asset Capital Life Science is a corporate venture arm and venture capital firm. Team members are concentrated in Boston, Massachusetts, United States. The known portfolio counts 4 companies, including Candid Therapeutics, Precede Biosciences, Accent Therapeutics and Attovia Therapeutics.
Is Mirae Asset Capital Life Science a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Who to pitch at Mirae Asset Capital Life Science
Mirae Asset Capital Life Science portfolio companies (4)
- Candid Therapeutics
- Precede Biosciences
- Accent Therapeutics
- Attovia Therapeutics
Co-investors
Funds that share portfolio companies with Mirae Asset Capital Life Science.
Similar funds
Showing 20 of 100
About Mirae Asset Capital Life Science
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Pharma; known deals cluster at Growth, Series A and Series B.
The contacts to approach at Mirae Asset Capital Life Science are Naveen Krishnan (Managing Director), David T. Paik (Investor) and Thomas Suter (Investor).
Across the known portfolio, 20 co-investors appear alongside Mirae Asset Capital Life Science, including venBio, Vida Ventures and Alexandria Real Estate Equities.
Frequently asked questions
What is Mirae Asset Capital Life Science?
Mirae Asset Capital Life Science is a corporate venture arm and venture capital firm whose team is concentrated in Boston, Massachusetts, United States, with a known portfolio of 4 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Mirae Asset Capital Life Science invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Mirae Asset Capital Life Science invest at?
The known deals of Mirae Asset Capital Life Science include Growth, Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Mirae Asset Capital Life Science?
All 3 people on file at Mirae Asset Capital Life Science are listed as contacts for the firm, each with their own profile page.
How do I contact Mirae Asset Capital Life Science?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 3 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal